Advanced search
Publication Cover
Substance Use & Misuse Volume 48, 2013 - Issue 8
Submit an article Journal homepage
892
Views
50
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Feasibility of Pharmacy-Based Naloxone Distribution Interventions: A Qualitative Study With Injection Drug Users and Pharmacy Staff in Rhode Island

Nickolas D. ZallerDivision of Infectious Diseases, The Miriam Hospital, Providence, Rhode Island, USACorrespondence[email protected]
,
Michael A. YokellStanford University School of Medicine, Stanford, California, USA
,
Traci Craig GreenThe Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
,
Julia GagginThe Fenway Institute, Boston, Massachusetts, USA
&
Patricia CaseThe Fenway Institute, Boston, Massachusetts, USA
Pages 590-599 | Published online: 10 Jun 2013

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Babak Tofighi, Daniele Martino, Helen-Maria Lekas, Sharifa Z. Williams, Chloe Blau & Crystal F. Lewis. (2023) Scaling opioid overdose prevention and naloxone dispensation among rural and small metro area pharmacists: findings from a qualitative study. Journal of Substance Use 28:4, pages 568-573.
Read now
Kristin E. Schneider, Lauren Dayton, Abigail K. Winiker, Karin E. Tobin & Carl A. Latkin. (2021) The role of overdose reversal training in knowing where to get naloxone: Implications for improving naloxone access among people who use drugs. Substance Abuse 42:4, pages 438-443.
Read now
Smita Das, Nina Shah & Murtuza Ghadiali. (2017) Intravenous use of intranasal naloxone: A case of overdose reversal. Substance Abuse 38:1, pages 18-21.
Read now
Amy Bachyrycz, Shikhar Shrestha, Barry E. Bleske, Dale Tinker & Ludmila N. Bakhireva. (2017) Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery. Substance Abuse 38:1, pages 55-60.
Read now
Robyn Dwyer, Suzanne Fraser & Paul Dietze. (2016) Benefits and barriers to expanding the availability of take-home naloxone in Australia: A qualitative interview study with service providers. Drugs: Education, Prevention and Policy 23:5, pages 388-396.
Read now
Mance E. Buttram & Steven P. Kurtz. (2016) Alternate Routes of Administration among Prescription Opioid Misusers and Associations with Sexual HIV Transmission Risk Behaviors. Journal of Psychoactive Drugs 48:3, pages 187-194.
Read now

Articles from other publishers (44)

Lena McDowell, Lindsey Hohmann & Rebecca Maxson. (2023) Impact of a Didactic-Experiential Naloxone Learning Model to Improve Student Pharmacist Skills and Patient Care. American Journal of Pharmaceutical Education, pages 100576.
Crossref
Minji Sohn, Chris Delcher, Jeffery C. Talbert, Yue Cheng, Yong Xu, Emmanuel D. Jadhav & Patricia R. Freeman. (2023) The Impact of Naloxone Coprescribing Mandates on Opioid-Involved Overdose Deaths. American Journal of Preventive Medicine 64:4, pages 483-491.
Crossref
Rachael K. Lai, Kelsie Ellis Friedson, Kelly R. Reveles, Kajal Bhakta, Gillian Gonzales, Lucas G. Hill & Kirk E. Evoy. (2022) Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review. Journal of the American Pharmacists Association 62:6, pages 1725-1740.
Crossref
Thomas Griner & Sheryl Strasser. (2021) A qualitative examination of responses from a survey of pharmacy staff in Georgia regarding access to Narcan®. Health Education Research 36:4, pages 467-477.
Crossref
Lucas Martignetti & Winnie Sun. (2022) Perspectives of Stakeholders of Equitable Access to Community Naloxone Programs: A Literature Review. Cureus.
Crossref
Jann B SkeltonVyishali Dharbhamalla. (2022) The role of managed care pharmacy in coprescribing naloxone for patients with specific risk: recommendations from the AMCP Addiction Advisory Group. Journal of Managed Care & Specialty Pharmacy 28:1, pages 100-106.
Crossref
Suzanne Nielsen & Anna Olsen. (2021) Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia. International Journal of Drug Policy 90, pages 103061.
Crossref
Heather M Santa, Samira G Amirova, Daniel J Ventricelli, George E Downs, Alexandra A Nowalk, Janice L Pringle & Meghana Aruru. (2021) Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order. American Journal of Health-System Pharmacy 78:4, pages 327-335.
Crossref
Taylor J. Holland, Jonathan Penm, Jacinta Johnson, Maria Sarantou & Betty B. Chaar. (2020) Stakeholders’ Perceptions of Factors Influencing the Use of Take-Home-Naloxone. Pharmacy 8:4, pages 232.
Crossref
Andy M. Nguyen, Thomas E. Kearney & Dorie E. Apollonio. (2020) Evaluation of naloxone furnishing community pharmacies in San Francisco. Journal of the American Pharmacists Association 60:6, pages 1050-1057.e1.
Crossref
Robin A. Pollini, Rebecca Joyce, Jenny E. Ozga-Hess, Ziming Xuan, Traci C. Green & Alexander Y. Walley. (2020) Assessing pharmacy-based naloxone access using an innovative purchase trial methodology. Journal of the American Pharmacists Association 60:6, pages 853-860.
Crossref
Amina Moustaqim-Barrette, Kristi Papamihali, Zahra Mamdani, Sierra Williams & Jane A. Buxton. (2020) Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data. PLOS ONE 15:9, pages e0238618.
Crossref
Keith Chichester, Michelle L. Sisson, Samantha P. Schiavon, Mickeah J. Hugley, Peter S. Hendricks, Richard C. Shelton & Karen L. Cropsey. (2020) Naloxone Training From Nonmedical Personnel: Benefits Before, During, and After Overdose Events. Journal of Addiction Medicine 14:5, pages e220-e225.
Crossref
Traci C. Green, Elizabeth Donovan, Brittany Klug, Patricia Case, Janette Baird, Dina Burstein, Abigail Tapper, Alexander Y. Walley & Jeffrey Bratberg. (2020) Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches. Journal of the American Pharmacists Association 60:5, pages 740-749.
Crossref
Christina A. Spivey, Angelica Wilder, Marie A. Chisholm-Burns, Sara Stallworth & James Wheeler. (2020) Evaluation of naloxone access, pricing, and barriers to dispensing in Tennessee retail community pharmacies. Journal of the American Pharmacists Association 60:5, pages 694-701.e1.
Crossref
Rosanna Smart, Caroline K. Geiger, Christopher M. Jones & Bradley D. Stein. (2020) Prescribers and Naloxone Pharmacy Claims. Journal of General Internal Medicine 35:8, pages 2475-2475.
Crossref
Rebecca L. Haffajee, Samantha Cherney & Rosanna Smart. (2020) Legal requirements and recommendations to prescribe naloxone. Drug and Alcohol Dependence 209, pages 107896.
Crossref
Dina Burstein, Janette Baird, Jeffrey Bratberg, Elizabeth Donovan, Ayorinde Soipe, Abigail Tapper, Patricia Case, Alexander Y. Walley & Traci C. Green. (2020) Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study. Journal of the American Pharmacists Association 60:2, pages 304-310.
Crossref
Tanvee Thakur, Meredith Frey & Betty Chewning. (2020) Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review. Journal of the American Pharmacists Association 60:1, pages 178-194.
Crossref
Michelle L. Sisson, Kristina B. McMahan, Keith R. Chichester, James W. Galbraith & Karen L. Cropsey. (2019) Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama. International Journal of Drug Policy 74, pages 229-235.
Crossref
Shawn Kurian, Brianna Baloy, Janette Baird, Dina Burstein, Ziming Xuan, Jeffrey Bratberg, Abigail Tapper, Alexander Walley & Traci C. Green. (2019) Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians. Journal of the American Pharmacists Association 59:6, pages 824-831.
Crossref
Micheal L Shier, John R Graham & Jennifer M Keogh. (2019) Social Work and the Emerging Opioid Epidemic: A Literature Review. The British Journal of Social Work.
Crossref
Zan M. DodsonEun-Hye Enki YooChristian Martin-GillRonald Roth. (2018) Spatial Methods to Enhance Public Health Surveillance and Resource Deployment in the Opioid Epidemic. American Journal of Public Health 108:9, pages 1191-1196.
Crossref
Zahava R. S. Rosenberg-Yunger, Moriah Ellen & Tim Mickleborough. (2018) The North American Opioid Experience and the Role of Community Pharmacy. Journal of Public Health Management and Practice 24:4, pages 301-305.
Crossref
Lauren C. Haggerty, Sharon S. Gatewood & Jean-Venable “Kelly” R. Goode. (2018) Public attitudes and beliefs about Virginia community pharmacists dispensing and administering naloxone. Journal of the American Pharmacists Association 58:4, pages S73-S77.e1.
Crossref
B.E. Meyerson, J.D. Agley, A. Davis, W. Jayawardene, A. Hoss, D.J. Shannon, P.T. Ryder, K. Ritchie & R. Gassman. (2018) Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016. Drug and Alcohol Dependence 188, pages 187-192.
Crossref
Adrian Farrugia, Suzanne Fraser & Robyn Dwyer. (2017) Assembling the Social and Political Dimensions of Take-Home Naloxone. Contemporary Drug Problems 44:3, pages 163-175.
Crossref
Traci C. Green, Patricia Case, Haley Fiske, Janette Baird, Shachan Cabral, Dina Burstein, Victoriana Schwartz, Nathan Potter, Alexander Y. Walley & Jeffrey Bratberg. (2017) Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. Journal of the American Pharmacists Association 57:2, pages S19-S27.e4.
Crossref
Thomas J. Stopka, Ashley Donahue, Marguerite Hutcheson & Traci C. Green. (2017) Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015. Journal of the American Pharmacists Association 57:2, pages S34-S44.
Crossref
Traci C. Green, Nathan Potter & Jeffrey Bratberg. (2017) Detecting naloxone prejudices in the pharmacy setting. Journal of the American Pharmacists Association 57:2, pages S10-S11.
Crossref
Allison Burrell, Laken Ethun, Jaime Allen Fawcett, Sherry Rickard-Aasen, Karl Williams, Shannon M. Kearney & Janice L. Pringle. (2017) The pharmacist's role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution. Journal of the American Pharmacists Association 57:2, pages S73-S77.e1.
Crossref
Amanda K. Gatewood, Michael J. Van Wert, Andrew P. Andrada & Pamela J. Surkan. (2016) Academic physicians' and medical students' perceived barriers toward bystander administered naloxone as an overdose prevention strategy. Addictive Behaviors 61, pages 40-46.
Crossref
Suzanne Nielsen & Marie Claire Van Hout. (2016) What is known about community pharmacy supply of naloxone? A scoping review. International Journal of Drug Policy 32, pages 24-33.
Crossref
Brandon D.L. Marshall, Traci C. Green, Jesse L. Yedinak & Scott E. Hadland. (2016) Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. International Journal of Drug Policy 31, pages 25-31.
Crossref
Christopher Rowe, Glenn-Milo Santos, Eric Vittinghoff, Eliza Wheeler, Peter Davidson & Philip O. Coffin. (2016) Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths. Journal of Urban Health 93:1, pages 117-130.
Crossref
Catriona Matheson, Manimekalai Thiruvothiyur, Helen Robertson & Christine Bond. (2016) Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development. International Journal of Drug Policy 27, pages 105-112.
Crossref
Traci C. Green, Emily F Dauria, Jeffrey Bratberg, Corey S. Davis & Alexander Y Walley. (2015) Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm Reduction Journal 12:1.
Crossref
Jeffrey Bratberg, Bill McLaughlin & Scott Brewster. (2015) Opioid overdose prevention. Journal of the American Pharmacists Association 55:5, pages 470-477.
Crossref
Crystal Fuller Lewis, Alexis V. Rivera, Natalie D. Crawford, Jennifer DeCuir & Silvia Amesty. (2015) Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City. Drug and Alcohol Dependence 153, pages 72-77.
Crossref
Michelle Geier & James J. Gasper. (2015) Naloxone prescribing by psychiatric clinical pharmacists for patients receiving opioid agonist treatment. Mental Health Clinician 5:1, pages 46-49.
Crossref
Maya Doe-Simkins, Emily Quinn, Ziming Xuan, Amy Sorensen-Alawad, Holly Hackman, Al Ozonoff & Alexander Y Walley. (2014) Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health 14:1.
Crossref
Richard J. Bodnar. (2014) Endogenous opiates and behavior: 2013. Peptides 62, pages 67-136.
Crossref
Gillian A. BeauchampErin L. WinstanleyShawn A. RyanMichael S. Lyons. (2014) Moving Beyond Misuse and Diversion: The Urgent Need to Consider the Role of Iatrogenic Addiction in the Current Opioid Epidemic. American Journal of Public Health 104:11, pages 2023-2029.
Crossref
Wende Wood. (2013) Harm reduction: A canadian perspective. Mental Health Clinician 3:6, pages 299-301.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.